These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9844127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats.
    Romero F, Rodríguez-Iturbe B, Parra G, González L, Herrera-Acosta J, Tapia E.
    Kidney Int; 1999 Mar; 55(3):945-55. PubMed ID: 10027931
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.
    Ventura CG, Coimbra TM, de Campos SB, de Castro I, Yu L, Seguro AC.
    J Am Soc Nephrol; 2002 Oct; 13(10):2524-33. PubMed ID: 12239241
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.
    Bloudícková S, Rajnoch J, Lodererová A, Honsová E, Viklický O.
    Kidney Blood Press Res; 2006 Oct; 29(1):60-6. PubMed ID: 16645304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.
    Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R.
    Kidney Int; 2003 Jan; 63(1):209-16. PubMed ID: 12472785
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of mycophenolate mofetil on glomerulosclerosis and renal oxidative stress in rats.
    Van den Branden C, Ceyssens B, Pauwels M, Van Wichelen G, Heirman I, Jie N, Verbeelen D.
    Nephron Exp Nephrol; 2003 Jan; 95(3):e93-9. PubMed ID: 14646361
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis.
    Suana AJ, Tuffin G, Frey BM, Knudsen L, Mühlfeld C, Rödder S, Marti HP.
    J Pharmacol Exp Ther; 2011 May; 337(2):411-22. PubMed ID: 21349934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
    Takeda S, Takahashi M, Sado Y, Takeuchi K, Hakamata Y, Shimizu H, Kaneko T, Yamamoto H, Ito C, Ookawara S, Asano Y, Kusano E, Kobayashi E.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effects of mycophenolate mofetil in ischemic acute renal failure in rats].
    Chávez-Velásquez M, Pons H, Medina M, Quiroz Y, Parra G, Herrera J.
    Nefrologia; 2007 Sep; 27(4):448-58. PubMed ID: 17944582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.